MINNEAPOLIS, Aug. 11 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI) announced today that it will present at the at the upcoming Noble Financial Fourth Annual Equity Conference which will be held Monday, August 18th - Tuesday, August 19th, 2008 at the Loews Lake Las Vegas Resort, NV. Dave Kaysen, President and Chief Executive Officer and Medi Jiwani, Vice President and Chief Financial Officer will discuss the Company's business strategy and historical financial performance at 9:30 a.m. Pacific Time on Monday, August 18th.
A live audio webcast of Uroplasty's presentation may be accessed through the Company's website at http://www.uroplasty.com. An archived replay of the presentation will be available after the live presentation, and can also be accessed at http://www.uroplasty.com.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with
wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a
medical device company that develops, manufactures and markets innovative
proprietary products for the treatment of voiding dysfunctions. Our primary
focus is the commercialization of our Urgent PC system, which we believe is
the only FDA-approved minimally invasive nerve stimulation device designed
for office-based treatment of urinary urgency, urinary frequency and urge
incontinence -- symptoms often associated with overactive bladder. We also
offer Macroplastique(R) Implants, an injectable bulking agent for the
treatment of adult female stress urinary incontinence pimarily due to
intrinsic sphincter deficiency. Please visit Uroplasty, Inc. at
For Further Information:
Uroplasty, Inc. EVC Group
David Kaysen, President and CEO, or Dahlia Bailey (Investors)
Medi Jiwani, Vice President, CFO, 415.896.5862
952.426.6140 Steve DiMattia/Chris Gale (Media)
|SOURCE Uroplasty, Inc.|
Copyright©2008 PR Newswire.
All rights reserved